Newsfeeds - Spark Newswire - Page 15

Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Read More

6 minute read

The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs

By Shanthi Rexaline

Today, 10:27 AM

Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies.

Read More

1 minute read

Pacific Biosciences To Buy DNA Sequencing Firm For Up To $800M, Announces $300M Capital Raise For Deal Funding

By Vandana Singh

Today, 10:27 AM

Pacific Biosciences of California Inc (NASDAQ:PACB) has agreed to acquire Omniome, a San Diego-based company developing a short-read sequencing platform. …

Read More

2 minute read

News

Pacific Biosciences Of California Reports Expansion Of Collaboration With Invitae

By Benzinga Newsdesk

Today, 10:27 AM

Collaboration to develop production-scale HiFi Sequencing platform expected to Include technology from Omniome, Inc. Combining both highly accurate long and short read sequencing technologies expected to provide deeper

Read More

1 minute read

Wells Fargo Maintains Equal-Weight on Invitae, Raises Price Target to $35

By Benzinga Newsdesk

Today, 10:27 AM

Wells Fargo analyst Dan Leonard maintains Invitae (NYSE:NVTA) with a Equal-Weight and raises the price target from $30 to $35.

Read More

16 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For June 15, 2021

By Benzinga Insights

Today, 10:27 AM

Read More

1 minute read

Raymond James Initiates Coverage On Invitae with Outperform Rating, Announces Price Target of $37

By Benzinga Newsdesk

Today, 10:27 AM

Raymond James analyst Andrew Cooper initiates coverage on Invitae (NYSE:NVTA) with a Outperform rating and announces Price Target of $37.

Read More

10 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For June 3, 2021

By Benzinga Insights

Today, 10:27 AM

Read More

1 minute read

Goldman Sachs Initiates Coverage On Invitae with Neutral Rating, Announces Price Target of $33

By Benzinga Newsdesk

Today, 10:27 AM

Goldman Sachs analyst Matthew Sykes initiates coverage on Invitae (NYSE:NVTA) with a Neutral rating and announces Price Target of $33.

Read More

2 minute read

Uncategorized

Cathie Wood Loads Up More On Peloton, Skillz, Teladoc On The Dip

Today, 10:27 AM

Cathie Wood-led Ark Investment Management snapped up over 3 million shares, worth about $48.53 million, in Skillz Inc (NYSE: SKLZ) on Wednesday.

Read More

1 minute read

Uncategorized

Invitae Shares Trading Lower As Q1 Earnings Lag Estimates, Contracting Margins

By Vandana Singh

Today, 10:27 AM

Invitae Corp (NYSE: NVTA) reported first-quarter FY21 results after the market closed Tuesday, wherein EPS loss of $0.63 came in worse than…